X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31109) 31109
Newsletter (3690) 3690
Newspaper Article (531) 531
Book Chapter (176) 176
Magazine Article (152) 152
Dissertation (50) 50
Book / eBook (36) 36
Streaming Video (19) 19
Conference Proceeding (12) 12
Reference (9) 9
Transcript (9) 9
Web Resource (9) 9
Book Review (4) 4
Publication (4) 4
Government Document (2) 2
Journal / eJournal (2) 2
Trade Publication Article (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23714) 23714
scleroderma (15303) 15303
female (13876) 13876
male (10774) 10774
middle aged (10715) 10715
systemic scleroderma (10271) 10271
adult (9659) 9659
rheumatology (7573) 7573
systemic sclerosis (6979) 6979
scleroderma, systemic - complications (6231) 6231
aged (6062) 6062
research (3951) 3951
scleroderma, systemic - pathology (3402) 3402
scleroderma, systemic - immunology (3366) 3366
systemic-sclerosis (3023) 3023
scleroderma, systemic - diagnosis (2883) 2883
scleroderma, systemic - physiopathology (2693) 2693
disease (2572) 2572
fibrosis (2445) 2445
medical research (2369) 2369
adolescent (2356) 2356
autoantibodies (2188) 2188
systemic lupus erythematosus (2188) 2188
scleroderma, systemic - drug therapy (2174) 2174
animals (2154) 2154
immunology (2147) 2147
medicine, experimental (2121) 2121
care and treatment (2031) 2031
skin (2029) 2029
dermatology (1957) 1957
risk factors (1845) 1845
analysis (1733) 1733
autoimmunity (1659) 1659
scleroderma, systemic (1643) 1643
diagnosis (1625) 1625
skin - pathology (1585) 1585
systemic-lupus-erythematosus (1563) 1563
medicine & public health (1513) 1513
scleroderma, systemic - blood (1471) 1471
autoimmune diseases (1460) 1460
prognosis (1440) 1440
medicine, general & internal (1434) 1434
scleroderma, systemic - metabolism (1418) 1418
classification (1417) 1417
child (1384) 1384
arthritis (1368) 1368
lupus (1321) 1321
diagnosis, differential (1308) 1308
case-control studies (1280) 1280
abridged index medicus (1264) 1264
rheumatoid-arthritis (1260) 1260
lupus erythematosus, systemic - immunology (1244) 1244
scleroderma, systemic - therapy (1235) 1235
pulmonary hypertension (1223) 1223
scleroderma, systemic - genetics (1220) 1220
treatment outcome (1211) 1211
pathogenesis (1179) 1179
prevalence (1176) 1176
antibodies (1136) 1136
severity of illness index (1133) 1133
expression (1126) 1126
health aspects (1076) 1076
mice (1068) 1068
lung diseases (1065) 1065
patients (1037) 1037
universities and colleges (1035) 1035
scleroderma, localized (1025) 1025
retrospective studies (1016) 1016
collagen (976) 976
fibroblasts (967) 967
mortality (940) 940
biopsy (926) 926
young adult (921) 921
inflammation (917) 917
rheumatoid arthritis (917) 917
aged, 80 and over (908) 908
hypertension (901) 901
scleroderma, systemic - diagnostic imaging (894) 894
autoantibodies - blood (878) 878
cells, cultured (873) 873
development and progression (850) 850
scleroderma, systemic - etiology (834) 834
research article (825) 825
lupus erythematosus, systemic - complications (812) 812
enzyme-linked immunosorbent assay (807) 807
time factors (803) 803
involvement (793) 793
survival (765) 765
respiratory system (758) 758
scleroderma, systemic - epidemiology (751) 751
radiography (740) 740
fibroblasts - metabolism (728) 728
internal medicine (727) 727
follow-up studies (725) 725
autoimmune diseases - immunology (719) 719
skin and connective tissue diseases (713) 713
sclerosis (710) 710
integumentary system (704) 704
autoantibodies - immunology (698) 698
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Online Resources - Online (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Reserve desk (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Reference (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30542) 30542
French (1360) 1360
German (1262) 1262
Russian (659) 659
Japanese (463) 463
Italian (440) 440
Spanish (389) 389
Polish (307) 307
Portuguese (133) 133
Chinese (82) 82
Czech (69) 69
Hungarian (42) 42
Korean (39) 39
Danish (33) 33
Dutch (32) 32
Croatian (31) 31
Romanian (26) 26
Turkish (22) 22
Swedish (21) 21
Slovak (18) 18
Hebrew (17) 17
Norwegian (17) 17
Finnish (11) 11
Serbian (11) 11
Bulgarian (9) 9
Ukrainian (7) 7
Persian (6) 6
Greek (3) 3
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Rheumatic disease clinics of North America, ISBN 141605863X, Volume 34, no. 1., xiii, 265
Book
Journal of the American Academy of Physician Assistants, ISSN 1547-1896, 10/2018, Volume 31, Issue 10, pp. 53 - 54
Journal Article
2003, Rheumatic disease clinics of North America, Volume 29, no. 2., xii, 211-448
Book
1966, Modern medical monographs, Volume 26, ix, 174
Book
Journal Article
Chest, ISSN 0012-3692, 04/2017, Volume 151, Issue 4, pp. 813 - 820
Background Cough is a common symptom of scleroderma-related interstitial lung disease (SSc-ILD... 
immunosuppressive therapy | health-related quality of life | interstitial lung disease | cough | scleroderma | TRIAL | RESPIRATORY SYSTEM | REFLEX | ORAL CYCLOPHOSPHAMIDE | QUESTIONNAIRE | VALIDITY | CRITICAL CARE MEDICINE | Severity of Illness Index | Cough - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Treatment Outcome | Lung Diseases, Interstitial - complications | Enzyme Inhibitors - therapeutic use | Lung Diseases, Interstitial - drug therapy | Cyclophosphamide - therapeutic use | Cough - etiology | Gastroesophageal Reflux - complications | Mycophenolic Acid - therapeutic use | Scleroderma, Systemic - complications | Quality of Life | Female | Respiratory Function Tests | Scleroderma, Systemic - drug therapy | Symptomatology | Chest | Care and treatment | Lung diseases, Interstitial | Systemic scleroderma | Analysis | Scleroderma (Disease) | Research | Risk factors | Cough | Quality of life | Diseases | MMF, mycophenolate mofetil | QILD, quantitative interstitial lung disease | Original Research | QLF, quantitative lung fibrosis | QoL, quality of life | GERD, gastroesophageal reflux disease | HRCT, high-resolution CT | TDI, transition dyspnea index | SSc-ILD, systemic sclerosis-related interstitial lung disease | BDI, baseline dyspnea index | RCT, randomized controlled trial | PPI, proton pump inhibitor | SLS, Scleroderma Lung Study | SGRQ, St. George’s Respiratory Questionnaire | ILD, interstitial lung disease | LM, lobe of maximal involvement | LCQ, Leicester Cough Questionnaire | SF-36, 36-item Short-Form Survey | Dlco, diffusing capacity of lung for carbon monoxide | VAS, visual analog scale | CYC, cyclophosphamide | WL, whole lung | FC, frequent cough | HAQ-DI, Health Assessment Questionnaire Disability Index | Signs and Symptoms of Chest Disease
Journal Article
Journal Article
Chest, ISSN 0012-3692, 11/2017, Volume 152, Issue 5, pp. 999 - 1007
Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in patients with scleroderma (Scl... 
systemic sclerosis | interstitial lung disease | prognosis | risk prediction | DIAGNOSIS | PHYSIOLOGY | GUIDELINES | CLINICAL CHARACTERISTICS | SYSTEMIC-SCLEROSIS | CIGARETTE-SMOKING | RESPIRATORY SYSTEM | IDIOPATHIC PULMONARY-FIBROSIS | HYPERTENSION | FORCED VITAL CAPACITY | PROGRESSION | CRITICAL CARE MEDICINE | Lung Diseases, Interstitial - etiology | Risk Assessment - methods | United States - epidemiology | Prognosis | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Tomography, X-Ray Computed | Disease Progression | Lung Diseases, Interstitial - mortality | Scleroderma, Systemic - diagnosis | Lung Diseases, Interstitial - diagnosis | Scleroderma, Systemic - mortality | Time Factors | Scleroderma, Systemic - complications | Cause of Death - trends | Female | Complications and side effects | Lung diseases, Interstitial | Care and treatment | Systemic scleroderma | Risk factors | Scleroderma (Disease) | UIP, usual interstitial pneumonia | ILD, interstitial lung disease | Scl, scleroderma | GERD, gastroesophageal reflux disease | Dlco, diffusing capacity of the lung for carbon monoxide | SADL, ever smoking history, age, and diffusing capacity of the lung for carbon monoxide (% predicted) | Chest Infection | Scl-ILD, scleroderma-related interstitial lung disease | IPF, idiopathic pulmonary fibrosis | PH, pulmonary hypertension | HRCT, high-resolution computed tomography | ANA, anti-nuclear antibody | RHC, right heart catheterization
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 2016, Volume 4, Issue 9, pp. 708 - 719
Journal Article